We are welcoming global collaborations to harness the advanced capabilities of the i-Core LNP nanocarrier platform through varying forms including but not limited to license-out, cooperative development and strategic alliance. Our strategic goal is to develop innovative products that rapidly meet clinical needs, ultimately benefiting a diverse patient population.
-
- Research Platform Cooperation
● RNA sequence Design and Optimization
● Ionizable Lipid Library-Based LNP Delivery System
● Targeted Drug Delivery via i-Core LNP Technology Platform
● Nucleic Acid Delivery Platform-Based Cell Therapies
Liver targeting (systemic administration)
Lung targeting (nebulized administration)
Skin targeting (local administration)
-
- Collaborative Pipeline Development
● Licensing Opportunities for Our Pipeline Products and Technologies
● Synergistic Combination Therapies with Our Clinical Candidates
● Collaborative Acceleration of Existing Projects towards Rapid Commercialization
